SIRT6 and breast carcinoma: Taking everything into consideration, their study shows that CK2 and SIRT6 are indicators of poor prognosis for breast carcinomas and that CK2-catalyzed phosphorylation of SIRT6 might be involved in the progression of breast carcinoma [227].